Primary proteasome inhibition results in cardiac dysfunction

European Journal of Heart Failure

Volumn 15, Issue 6, 2013, Pages 614-623

  Herrmann, Joerg ^a   Wohlert, Christine ^a   Saguner, Ardan M ^a   Flores, Ana ^a   Nesbitt, Lisa L ^a   Chade, Alejandro ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

Cardiomyopathy; Heart failure; Proteasome

Indexed keywords

ADENOSINE; DOBUTAMINE; MLN 273; PROTEASOME; PROTEASOME INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DIET; ELECTRON BEAM TOMOGRAPHY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INHIBITION; EX VIVO STUDY; FEMALE; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART MUSCLE PERFUSION; HEART OUTPUT; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STAINING; SWINE; UBIQUITINATION;

CARDIOMYOPATHY; HEART FAILURE; PROTEASOME;

ADENOSINE; ANIMALS; BORONIC ACIDS; CAPILLARY PERMEABILITY; CARDIOTONIC AGENTS; DIPEPTIDES; DOBUTAMINE; FEMALE; HEART; IN SITU NICK-END LABELING; MYOCARDIAL PERFUSION IMAGING; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; STROKE VOLUME; SWINE; TOMOGRAPHY, X-RAY COMPUTED; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 84878272968     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hft034     Document Type: Article

References (45)

1. Herrmann J, Ciechanover A, Lerman LO, Lerman A. The ubiquitin-proteasome system in cardiovascular diseases - a hypothesis extended. Cardiovasc Res 2004; 61: 11-21.
2. Shringarpure R, Grune T, Mehlhase J, Davies KJ. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem 2003; 278: 311-318.
3. Powell SR, Wang P, Divald A, Teichberg S, Haridas V, McCloskey TW, Davies KJ, Katzeff H. Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. Free Radic Biol Med 2005; 38: 1093-1101.
4. Liu J, Chen Q, Huang W, Horak KM, Zheng H, Mestril R, Wang X. Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts. FASEB J 2006; 20: 362-364.
5. Chen Q, Liu JB, Horak KM, Zheng H, Kumarapeli AR, Li J, Li F, Gerdes AM, Wawrousek EF, Wang X. Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Circ Res 2005; 97: 1018-1026.
6. Sanbe A, Osinska H, Saffitz JE, Glabe CG, Kayed R, Maloyan A, Robbins J. Desminrelated cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc Natl Acad Sci USA 2004; 101: 10132-10136.
7. Wang X, Robbins J. Heart failure and protein quality control. Circ Res 2006; 99: 1315-1328.
8. Patterson C, Ike C, Willis PWt, Stouffer GA, Willis MS. The bitter end: the ubiquitin- proteasome system and cardiac dysfunction. Circulation 2007; 115: 1456-1463.
9. Tsukamoto O, Minamino T, Okada K, Shintani Y, Takashima S, Kato H, Liao Y, Okazaki H, Asai M, Hirata A, Fujita M, Asano Y, Yamazaki S, Asanuma H, Hori M, Kitakaze M. Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Biochem Biophys Res Commun 2006; 340: 1125-1133.
10. Fu HY, Minamino T, Tsukamoto O, Sawada T, Asai M, Kato H, Asano Y, Fujita M, Takashima S, Hori M, Kitakaze M. Overexpression of endoplasmic reticulumresident chaperone attenuates cardiomyocyte death induced by proteasome inhibition. Cardiovasc Res 2008; 79: 600-610.
11. Herrmann J, Saguner AM, Versari D, Peterson TE, Chade A, Olson M, Lerman LO, Lerman A. Chronic proteasome inhibition contributes to coronary atherosclerosis. Circ Res 2007; 10: 865-874.
12. Daghini E, Ritman EL, Lerman LO. Examine thy heart with all diligence: evaluation of cardiac function using fast computed tomography. Hypertension 2007; 49: 249-256.
13. Zhu XY, Daghini E, Rodriguez-Porcel M, Chade AR, Napoli C, Lerman A, Lerman LO. Redox-sensitive myocardial remodeling and dysfunction in swine diet-induced experimental hypercholesterolemia. Atherosclerosis 2007; 193: 62-69.
14. Mannheim D, Herrmann J, Bonetti PO, Lavi R, Lerman LO, Lerman A. Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effect. Atherosclerosis 2011; 216: 283-291.
15. Kuroda T, Seward JB, Rumberger JA, Yanagi H, Tajik AJ. Left ventricular volume and mass: comparative study of two-dimensional echocardiography and ultrafast computed tomography. Echocardiography 1994; 11: 1-9.
16. Rumberger JA. Use of electron beam tomography to quantify cardiac diastolic function. Cardiol Clin 2000; 18: 547-556.
17. Rodriguez-Porcel M, Lerman A, Best PJ, Krier JD, Napoli C, Lerman LO. Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity. J Am Coll Cardiol 2001; 37: 608-615.
18. Rosenfeldt MT, Nixon C, Liu E, Mah LY, Ryan KM. Analysis of macroautophagy by immunohistochemistry. Autophagy 2012: 8: 963-969.
19. Woodrum DA, Herrmann J, Lerman A, Romano AJ, Lerman LO, Ehman RL. Phase-contrast MRI-based elastography technique detects early hypertensive changes in ex vivo porcine aortic wall. J Magn Reson Imaging 2009; 29: 583-587.
20. Predmore JM, Wang P, Davis F, Bartolone S, Westfall MV, Dyke DB, Pagani F, Powell SR, Day SM. Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation 2010; 121: 997-1004.
21. Depre C, Wang Q, Yan L, Hedhli N, Peter P, Chen L, Hong C, Hittinger L, Ghaleh B, Sadoshima J, Vatner DE, Vatner SF, Madura K. Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation 2006; 114: 1821-1828.
22. Tang M, Li J, Huang W, Su H, Liang Q, Tian Z, Horak KM, Molkentin JD, Wang X. Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts. Cardiovasc Res 2010; 88: 424-433.
23. Segura AM, Frazier OH, Buja LM. Fibrosis and heart failure. Heart Fail Rev 2012; in press.
24. Meiners S, Hocher B, Weller A, Laule M, Stangl V, Guenther C, Godes M, Mrozikiewicz A, Baumann G, Stangl K. Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome. Hypertension 2004; 44: 471-477.
25. Oh JK, Hatle L, Tajik AJ, Little WC. Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 2006; 47: 500-506.
26. Rumberger JA. Use of electron beam tomography to quantify cardiac diastolic function. Cardiol Clin 2000; 18: 547-556.
27. Varagic J, Frohlich ED, Diez J, Susic D, Ahn J, Gonzalez A, Lopez B. Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in saltloaded SHR. Am J Physiol Heart Circ Physiol 2006; 290: H1503-H1509.
28. Thuerauf DJ, Hoover H, Meller J, Hernandez J, Su L, Andrews C, Dillmann WH, McDonough PM, Glembotski CC. Sarco/endoplasmic reticulum calcium ATPase-2 expression is regulated by ATF6 during the endoplasmic reticulum stress response: intracellular signaling of calcium stress in a cardiac myocyte model system. J Biol Chem 2001; 276: 48309-48317.
29. Enrico O, Gabriele B, Nadia C, Sara G, Daniele V, Giulia C, Antonio S, Mario P. Unexpected cardiotoxicity in haematological bortezomib treated patients. Br J Haematol 2007; 138: 396-397.
30. Akoum N, McGann C, Vergara G, Badger T, Ranjan R, Mahnkopf C, Kholmovski E, Macleod R, Marrouche N. Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant. J Cardiovasc Electrophysiol 2012; 23: 44-50.
31. Stangl K, Gunther C, Frank T, Lorenz M, Meiners S, Ropke T, Stelter L, Moobed M, Baumann G, Kloetzel PM, Stangl V. Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection. Biochem Biophys Res Commun 2002; 291: 542-549.
32. Campbell B, Adams J, Shin YK, Lefer AM. Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart. J Mol Cell Cardiol 1999; 31: 467-476.
33. Powell SR, Gurzenda EM, Teichberg S, Mantell LL, Maulik D. Association of increased ubiquitinated proteins with cardiac apoptosis. Antioxid Redox Signal 2000; 2: 103-112.
34. Patel MB, Majetschak M. Distribution and interrelationship of ubiquitin proteasome pathway component activities and ubiquitin pools in various porcine tissues. Physiol Res 2007; 56: 341-350.
35. Hacihanefioglu A, Tarkun P, Gonullu E. Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib. Int J Hematol 2008; 88: 219-222.
36. Eschenhagen T, Force T, Ewer MS, de Keulenaer GW, Suter TM, Anker SD, Avkiran M, de Azambuja E, Balligand JL, Brutsaert DL, Condorelli G, Hansen A, Heymans S, Hill JA, Hirsch E, Hilfiker-Kleiner D, Janssens S, de Jong S, Neubauer G, Pieske B, Ponikowski P, Pirmohamed M, Rauchhaus M, Sawyer D, Sugden PH, Wojta J, Zannad F, Shah AM. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2011; 13: 1-10.
37. Ding WX, Ni HM, Chen X, Yu J, Zhang L, Yin XM. A coordinated action of Bax, PUMA, and p53 promotes MG132-induced mitochondria activation and apoptosis in colon cancer cells. Mol Cancer Ther 2007; 6: 1062-1069.
38. Birks EJ, Latif N, Enesa K, Folkvang T, Luong le A, Sarathchandra P, Khan M, Ovaa H, Terracciano CM, Barton PJ, Yacoub MH, Evans PC. Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy. Cardiovasc Res 2008; 79: 472-480.
39. Nickson P, Toth A, Erhardt P. PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress. Cardiovasc Res 2007; 73: 48-56.
40. Okada K, Minamino T, Tsukamoto Y, Liao Y, Tsukamoto O, Takashima S, Hirata A, Fujita M, Nagamachi Y, Nakatani T, Yutani C, Ozawa K, Ogawa S, Tomoike H, Hori M, Kitakaze M. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 2004; 110: 705-712.
41. Kuusisto E, Suuronen T, Salminen A. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem Biophys Res Commun 2001; 280: 223-228.
42. Zheng Q, Su H, Tian Z, Wang X. Proteasome malfunction activates macroautophagy in the heart. Am J Cardiovasc Dis 2011; 1: 214-226.
43. Martinet W, De Meyer GR, Andries L, Herman AG, Kockx MM. Detection of autophagy in tissue by standard immunohistochemistry: possibilities and limitations. Autophagy 2006; 2: 55-57.
44. Tian Z, Zheng H, Li J, Li Y, Su H,Wang X. Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemiareperfusion injury in mice. Circ Res 2012; 111: 532-542.
45. Chaanine AH, Hajjar RJ. AKT signalling in the failing heart. Eur J Heart Fail 2011; 13: 825-829.